Extract
Alcon Amends NDA for Patanase(R) Nasal Spray.
HUENENBERG, Switzerland -- Alcon, Inc. (NYSE: ACL) announced today that it has submitted to the U.S. Food and Drug Administration (FDA) an amendment to its pending new drug application (NDA) for PATANASE([R]) (olopatadine hydrochloride) nas...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
notice of incorporation | what lies ahead? utes plan to move on from bcs season | letters to editor health care a must | campus notes. | Decisión nº PJ0082006000152 de Tribunal Octavo de Primera Instancia de Sustancia... | decisión de juzgado sexto primera instancia en lo civil mercantil y del transito de caracas de february 02 2011 | Decisión de Juzgado Superior Segundo en lo Civil Mercantil de Lara de October 07 2010 | decisión de juzgado vigesimo primero de municipio de caracas de april 15 2010
